tetano
Editor, Senior Moderator
Emerg Infect Dis. 2012 Mar;18(3):534-5. doi: 10.3201/eid1803.111351.
Adherence to Oseltamivir Guidelines during Influenza Pandemic, the Netherlands.
Fietj? EH, Philbert D, van Geffen EC, Winters NA, Bouvy ML.
Abstract
TO THE EDITOR: In the Netherlands, the outbreak of pandemic influenza A (H1N1) 2009 led to a 100-fold increase from 2008 in prescriptions for the antiviral neuraminidase inhibitor oseltamivir (1). The guidelines for prescribing oseltamivir during the 2009 pandemic were adapted throughout the year. After August 7, prescribers were advised to restrict prescriptions to patients with influenza symptoms plus 1 additional risk factor (2) (Table).
PMID:
22377063
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/22377063
Adherence to Oseltamivir Guidelines during Influenza Pandemic, the Netherlands.
Fietj? EH, Philbert D, van Geffen EC, Winters NA, Bouvy ML.
Abstract
TO THE EDITOR: In the Netherlands, the outbreak of pandemic influenza A (H1N1) 2009 led to a 100-fold increase from 2008 in prescriptions for the antiviral neuraminidase inhibitor oseltamivir (1). The guidelines for prescribing oseltamivir during the 2009 pandemic were adapted throughout the year. After August 7, prescribers were advised to restrict prescriptions to patients with influenza symptoms plus 1 additional risk factor (2) (Table).
PMID:
22377063
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/22377063